Reports

The Oregon Prescription Drug Affordability Board is pleased to provide the generic drug report for the Oregon Legislature as required by Senate Bill 844, the board's founding legislation. The 15-page report has these components:

• Executive Summary, Page 4
  
• Introduction, Page 6
  
• Generic drug products, Page 12
  
• Oregon and generics, Page 11
  
• Biologic and biosimilars, Page 12
  
• Effects of generics and biosimilars on spending, premiums, Page 15
  

View the 2023 report